IRCT20210906052395N1已完成3 期
Assessment of Empagliflozin effect on renal outcome in patients with type 2 diabetes mellitus
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patient with type2 diabetes
- •over the age of 18 years
- •GFR<60 or albuminuria
排除标准
- •Recent myocatdial infarction and PCI
- •Dialysis in the last ninety days
- •Renal failure for reasons other than diabetes
- •Recurrent urinary tract infections
- •History of amputation due to diabetes
- •Bladder cancer
- •Active diabetic foot ulcer
- •type 1 diabetes
- •Pregnancy and lactation
- •Major surgery performed in the last 28 days
研究者
相似试验
招募中
4 期
Effect of empagliflozin on renal events in non-diabetic chronic kidney disease patientsChronic kidney disease.Chronic kidney disease (CKD)IRCT20211104052965N1Shahid Beheshti University of Medical Sciences458
进行中（未招募）
1 期
Effect of treatment with Empagliflozin alone or in combination with Semaglutide on protein in the urine in persons with type 2 diabetes and elevated urinary protein.Type 2 diabetes with renal complicationsMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-003175-19-DKSteno Diabetes Center Copenhagen80
进行中（未招募）
1 期
Effects of empagliflozin on urine output and renal function in patients with acute heart failureMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 100000004849acute decompensated heart failureEUCTR2018-003692-35-DEFriedrich Schiller University Jena60
Unknown
4 期
Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and AlbuminuriaType 2 Diabetes With Renal ManifestationsNCT04061200Steno Diabetes Center Copenhagen80
招募中
2 期
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis PatientsEnd Stage Renal Disease on DialysisPeritoneal Dialysis ComplicationSodium-glucose Cotransporter-2 InhibitorResidual Kidney FunctionNCT06483074Chinese University of Hong Kong48